INS and metabolic syndrome: Dyslipidemia refers to a triad of abnormal lipid and lipoprotein metabolism.1 Dyslipidemia among type 2 diabetes mellitus (T2DM) is an important modifiable risk factor for atherosclerosis, stroke and cardiovascular diseases (CVD).2 It is mainly due to increased free fatty acids flux secondary to insulin resistance.3